Intrexon | XON - Loan Capital

Stock Price
3.31
Daily Change
-0.25 -6.90%
Monthly
-22.05%
Yearly
71.24%
Q1 Forecast
3.67

Intrexon reported $0 in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Agenus USD 23.6M 448K Sep/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Amgen USD 50B 2.43B Dec/2025
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Incyte USD 30.2M 5.17M Dec/2025
Intrexon USD 0 198.67M Jun/2024
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
MacroGenics USD 70.26M 4K Sep/2025
MannKind USD 548.44M 244.79M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Rigel Pharmaceuticals USD 0 0 Sep/2024
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Veracyte USD 0 0 Mar/2025
Xencor USD 76.48M 11.29M Dec/2025